+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urinary Tract Infection Testing Market by Test Type (Automated Urinalysis, Culture Test, Molecular Test), Technology (Automated Systems, Culture Based, Immunoassays), End User, Distribution Channel, Sample Type - Global Forecast 2025-2030- Product Image
Urinary Tract Infection Testing Market by Test Type (Automated Urinalysis, Culture Test, Molecular Test), Technology (Automated Systems, Culture Based, Immunoassays), End User, Distribution Channel, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Urinary Tract Infection Testing Market by Test Type (Automated Urinalysis, Culture Test, Molecular Test), Technology (Automated Systems, Culture Based, Immunoassays), End User, Distribution Channel, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666357
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The urinary tract infection testing market is evolving rapidly, fueled by technological advances and the optimization of clinical workflows. Senior decision-makers can leverage this transformation to streamline diagnostics, improve patient care, and strengthen compliance within their institutions.

Market Snapshot: Urinary Tract Infection Testing Market Growth and Dynamics

The urinary tract infection testing market is witnessing consistent growth, underpinned by rising demand for rapid diagnostics and improved test accuracy. This trajectory is supported by advancements in automated systems, the increasing integration of molecular diagnostic technologies, and growing pressures to optimize healthcare resources. Industry stakeholders, including diagnostic laboratories, healthcare providers, and manufacturers, are responding to evolving clinical requirements, regulatory changes, and operational challenges, making this sector highly dynamic and competitive.

Scope & Segmentation: Comprehensive Overview of the Urinary Tract Infection Testing Market

  • Test Types: Automated urinalysis (microscopy, digital imaging, flow cytometry), culture tests, molecular tests (isothermal amplification, next-generation sequencing, PCR assay), and rapid tests (dipstick, microscopy)
  • Technologies: Automated systems (fully and semi-automated), culture-based, immunoassays (chemiluminescent immunoassay, ELISA, lateral flow assay), molecular diagnostics (isothermal amplification, next-generation sequencing, PCR)
  • End Users: Clinics, diagnostic laboratories, home care providers, and hospitals
  • Distribution Channels: Direct tender, e-commerce, hospital pharmacy, and retail pharmacy
  • Sample Types: Catheterized, midstream clean catch, suprapubic aspiration
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina, and key US states), Europe, Middle East & Africa (with detailed country breakdowns), Asia-Pacific (covering China, India, Japan, Australia, South Korea, and additional regional markets)
  • Key Companies: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., bioMérieux SA, Sysmex Corporation, Ortho Clinical Diagnostics, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Automated urinalysis platforms are setting new benchmarks for throughput, supporting faster diagnostics and operational efficiency across clinical settings.
  • Molecular testing solutions enhance rapid pathogen identification, directly supporting improved patient management and the implementation of targeted antimicrobial therapies.
  • Collaborative developments between instrument manufacturers and reagent suppliers foster greater interoperability, ensuring seamless integration of new diagnostic systems.
  • Point-of-care tests and decentralized platforms continue to increase test accessibility, particularly in regions with limited laboratory infrastructure.
  • Regional differences in technology adoption highlight the need for tailored market strategies that align with local healthcare policies and infrastructure maturity.
  • Advancements in AI-driven analytics are improving interpretive accuracy and supporting end-to-end diagnostic workflows for enhanced clinical outcomes.

Tariff Impact: Regulatory and Cost Dynamics in the United States

Recent tariffs have impacted the import costs of reagents and diagnostic equipment in the US, prompting manufacturers to reassess supply chains and source domestically where feasible. These policy changes are driving adjustments to pricing structures and encouraging closer collaboration between local instrument manufacturers and reagent providers. Laboratories are responding by optimizing inventory management and extending reagent shelf lives through stricter protocols, demonstrating industry resilience under shifting regulatory landscapes.

Methodology & Data Sources: Rigorous Research Approach

This report is built on a robust combination of primary and secondary research. Primary data collection included interviews with senior leaders from diagnostic companies, laboratories, and regulatory bodies. Secondary sources spanned peer-reviewed literature, market analyses, clinical guidelines, and procurement datasets. Analytical frameworks such as SWOT and Porter’s Five Forces informed the competitive and strategic insights presented.

Why This Report Matters: Decision-Ready Intelligence

  • Delivers in-depth, actionable intelligence to inform strategic planning and technology adoption in the urinary tract infection testing market.
  • Equips senior leaders with critical insights into regional dynamics, regulatory changes, and the growing importance of supply chain resilience.
  • Offers clear segmentation and competitor profiles, enabling more effective investment decisions and identification of partnership opportunities.

Conclusion

The urinary tract infection testing market is experiencing significant transformation, shaped by technological advancements and regulatory shifts. Organizations that proactively adapt to these changes will be well positioned to meet rising clinical expectations and secure competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of smartphone-based urine analysis apps for real-time UTI screening
5.2. Development of point-of-care molecular diagnostics for antibiotic-resistant UTI pathogens
5.3. Adoption of telehealth-enabled home UTI testing kits with integrated clinician feedback
5.4. Implementation of AI-powered image analysis for automated urinary sediment evaluation
5.5. Expansion of multiplex PCR panels detecting emerging multidrug-resistant UTI strains
5.6. Use of next-generation sequencing for comprehensive urinary microbiome profiling in UTI diagnosis
5.7. Rising demand for rapid dipstick tests with improved specificity for asymptomatic UTI screening
5.8. Integration of cloud-based data analytics for UTI test result benchmarking and surveillance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Urinary Tract Infection Testing Market, by Test Type
8.1. Introduction
8.2. Automated Urinalysis
8.2.1. Automated Microscopy
8.2.2. Digital Imaging
8.2.3. Flow Cytometry
8.3. Culture Test
8.4. Molecular Test
8.4.1. Isothermal Amplification
8.4.2. Next Generation Sequencing
8.4.3. Pcr Assay
8.5. Rapid Test
8.5.1. Dipstick Test
8.5.2. Microscopy
9. Urinary Tract Infection Testing Market, by Technology
9.1. Introduction
9.2. Automated Systems
9.2.1. Fully Automated
9.2.2. Semi Automated
9.3. Culture Based
9.4. Immunoassays
9.4.1. Chemiluminescent Immunoassay
9.4.2. Elisa
9.4.3. Lateral Flow Assay
9.5. Molecular Diagnostics
9.5.1. Isothermal
9.5.2. Next Generation Sequencing
9.5.3. Pcr
10. Urinary Tract Infection Testing Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Diagnostic Laboratories
10.4. Home Care
10.5. Hospitals
11. Urinary Tract Infection Testing Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.3. E Commerce
11.4. Hospital Pharmacy
11.5. Retail Pharmacy
12. Urinary Tract Infection Testing Market, by Sample Type
12.1. Introduction
12.2. Catheterized
12.3. Midstream Clean Catch
12.4. Suprapubic Aspiration
13. Americas Urinary Tract Infection Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Urinary Tract Infection Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Urinary Tract Infection Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Danaher Corporation
16.3.4. Siemens Healthineers AG
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. bioMérieux SA
16.3.7. Sysmex Corporation
16.3.8. Ortho Clinical Diagnostics, Inc.
16.3.9. QIAGEN N.V.
16.3.10. Bio-Rad Laboratories, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. URINARY TRACT INFECTION TESTING MARKET: RESEARCHAI
FIGURE 26. URINARY TRACT INFECTION TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. URINARY TRACT INFECTION TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. URINARY TRACT INFECTION TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIPSTICK TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIPSTICK TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CATHETERIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CATHETERIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MIDSTREAM CLEAN CATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MIDSTREAM CLEAN CATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUPRAPUBIC ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUPRAPUBIC ASPIRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 152. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 153. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 154. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 155. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 156. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 157. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 160. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 161. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 162. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 163. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 164. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 165. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 176. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 177. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 178. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 179. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 284. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 285. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2024 (USD MILLION)
TABLE 286. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 288. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 289. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 290. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 291. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Urinary Tract Infection Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Sysmex Corporation
  • Ortho Clinical Diagnostics, Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.94 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Urinary Tract Infection Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company) - Product Image

Urinary Tract Infection Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • Report
  • 270 Pages
  • Global
From
Urinary Tract Infection Testing Devices Market Report 2025 - Product Image

Urinary Tract Infection Testing Devices Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Urinary Tract Infection Testing - Global Strategic Business Report - Product Image

Urinary Tract Infection Testing - Global Strategic Business Report

  • Report
  • 300 Pages
  • Global
From
Hospital-acquired Urinary Tract Infection Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Hospital-acquired Urinary Tract Infection Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 114 Pages
  • Global
From

About the Urinary Tract Infection Testing Market

The Urinary Tract Infection (UTI) Testing market is a subset of the Urology and Nephrology industry. It is focused on the diagnosis and treatment of UTIs, which are caused by bacteria entering the urinary tract. UTI testing is used to identify the presence of bacteria in the urine, as well as to determine the type of bacteria present. Tests may include urine cultures, urine microscopy, and urine antigen tests. Treatment typically involves antibiotics, and in some cases, surgery. The UTI Testing market is driven by the increasing prevalence of UTIs, as well as the need for accurate diagnosis and treatment. The market is expected to grow in the coming years, as new technologies and treatments are developed. Some companies in the UTI Testing market include Siemens Healthineers, Abbott Laboratories, Becton Dickinson, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.